Prognostic role of pigment epithelium-derived factor in clear cell renal cell carcinoma

Urologia Internationalis

Volumn 84, Issue 3, 2010, Pages 334-340

  Jiang, Zhaohui ^a   Fang, Zhujun ^a   Ding, Qiang ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Pigment epithelium derived factor; Renal cell carcinoma

Indexed keywords

PIGMENT EPITHELIUM DERIVED FACTOR;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLEAR CELL CARCINOMA; CLEAR CELL RENAL CELL CARCINOMA; CLINICAL FEATURE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

CARCINOMA, RENAL CELL; EYE PROTEINS; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PROGNOSIS; RETROSPECTIVE STUDIES; SERPINS; SURVIVAL RATE;

EID: 77951123229     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000288239     Document Type: Article

References (29)

1. Kovacs G, Akhtar M, Beckwith BJ, Bugert P, Cooper CS, Delahunt B, Eble JN, Fleming S, Ljungberg B, Medeiros LJ, Moch H, Reuter VE, Ritz E, Roos G, Schmidt D, Srigley JR, Storkel S, Van Den Berg E, Zbar B: The Heidelberg classification of renal cell tumours. J Pathol 1997; 183: 131-133.
2. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H: An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis the SSIGN score. J Urol 2002; 168: 2395-2400.
3. Tombran-Tink J, Chader GG, Johnson LV: PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991; 53: 411-414.
4. Ek ET, Dass CR, Choong PF: Pigment epithelium- derived factor: a multimodal tumor inhibitor. Mol Cancer Ther 2006; 5: 1641-1646.
5. Pina AL, Kubitza M, Brawanski A, Tombran- Tink J, Kloth S: Expression of pigment-epithelium- derived factor during kidney development and aging. Cell Tissue Res 2007; 329: 329-338.
6. Abramson LP, Stellmach V, Doll JA, Cornwell M, Arensman RM: Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model. J Pediatr Surg 2003; 38: 336-342.
7. Weidner N, Semple JP, Welch WR, Folkman J: Tumor angiogenesis and metastasis - correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
8. Fontanini G, Bigini D, Vignati S, Basolo F, Mussi A, Lucchi M, Chine S, Angeletti CA, Harris AL, Bevilacqua G: Microvessel count predicts metastatic disease and survival in non-small cell lung cancer. J Pathol 1995; 177: 57-63.
9. Hollingsworth HC, Kohn EC, Steinberg SM, Rothenberg ML, Merino MJ: Tumor angiogenesis in advanced staged ovarian carcinoma. Am J Pathol 1995; 147: 33-41.
10. Srivastava A, Laidler P, Davies RP, Horgan K, Hughes LE: The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma: a quantitative histologic study. Am J Pathol 1988; 133: 419-423.
11. Guang-Wu H, Sunagawa M, Jie-En L, Shimada S, Gang Z, Tokeshi Y, Kosugi T: The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. Laryngoscope 2000; 110: 2066-2069.
12. Ohta M, Konno H, Tanaka T, Baba M, Kamiya K, Syouji T, Kondoh K, Watanabe M, Terada H, Nakamura S: The significance of circulating vascular endothelial growth factor (VEGF) protein in gastric cancer. Cancer Lett 2003; 192: 215-225.
13. Seo Y, Baba H, Fukuda T, Takashima M, Sugimachi K: High expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinoma. Cancer 2000; 88: 2239-2245.
14. Yoshino S, Kato M, Okada K: Evaluation of the prognostic significance of microvessel count and tumor size in renal cell carcinoma. Int J Urol 1998; 2: 119-123.
15. Paradis V, Lagha NB, Zeimoura L, Blanchet P, Eschwege P, Ba N, Benoit G, Jardin A, Bedossa P: Expression of vascular endothelial growth factor in renal cell carcinomas. Virchows Arch 2000; 436: 351-356.
16. Good DJ, Polverini PJ, Rastinejad F, Beau MML, Lemons RS, Frazier WA, Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 1990; 87: 6624-6628.
17. O'Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, Flynn E, Birkhead JR, Olsen BR, Folkman J: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-285.
18. Dawson DW, Volpert OV, Gillis P, Crawford SE, Xu H, Benedict W, Bouck NP: Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999; 285: 245-248.
19. Bilak MM, Corse AM, Bilak SR, Lehar M, Tombran-Tink J, Kuncl RW: Pigment epithelium- derived factor(PEDF) protects motor neurons from chronic glutamate-mediated neurodegeneration. J Neuropathol Exp Neurol 1999; 58: 719-728.
20. Kuncl RW, Bilak MM, Bilak SR, Corse AM, Royal W, Becerra SP: Pigment epitheliumderived factor is elevated in CSF of patients with amyotrophic lateral sclerosis. J Neurochem 2002; 81: 178-184.
21. Petersen SV, Valnickova Z, Enghild JJ: Pigment epithelium-derived factor (PEDF) occurs at a physiologically relevant concentration in human blood: purification and characterization. Biochem J 2003; 374: 199-206.
22. Sawant S, Aparicio S, Tink AR, Lara N, Barnstable CJ, Tombran-Tink J: Regulation of factors controlling angiogenesis in liver development: a role for PEDF in the formation and maintenance of normal vasculature. Biochem Biophys Res Commun 2004; 325: 408-413.
23. Quan GM, Ojaimi J, Li Y, Kartsogiannis V, Zhou H, Choong PF: Localization of pigment epithelium-derived factor in growing mouse bone. Calcif Tissue Int 2005; 76: 146-153.
24. Tombran-Tink J, Mazuruk K, Rodriguez IR, Chung D, Linker T, Englander E, Chader GJ: Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. Mol Vis 1996; 2: 11.
25. Halin S, Wikstrom P, Rudolfsson SH, Stattin P, Doll JA, Crawford SE, Bergh A: Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors. Cancer Res 2004; 64: 5664-5671.
26. Uehara H, Miyamoto M, Kato K, Ebihara Y, Kaneko H, Hashimoto H, Murakami Y, Hase R: Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res 2004; 64: 3533-3537.
27. Crawford SE, Stellmach V, Ranalli M, Huang X, Huang L, Volpert O, De Vries GH, Abramson LP, Bouck N: Pigment epithelium- derived factor (PEDF) in neuroblastoma: a multifunctional mediator of Schwann cell antitumor activity. J Cell Sci 2001; 114: 4421-4428.
28. Guan M, Yam HF, Su B, Chan KP, Pang CP, Liu WW, Zhang WZ, Lu Y: Loss of pigment epithelium derived factor expression in glioma progression. J Clin Pathol 2003; 56: 277-282.
29. Abramson LP, Stellmach V, Doll JA, Cornwell M, Arensman RM, Crawford SE: Wilms' tumor growth is suppressed by antiangiogenic pigment epithelium-derived factor in a xenograft model. J Pediatr Surg 2003; 38: 336-342.